Credit card and PayPal contributions are working again. If you saw a "temporarily unavailable" message between October 10 and 14, we apologize - please try again. Thank you for supporting QuantumOnline.com.
Starling Oncology, Inc. (STLN)
NCM · Common · CUSIP 68236X100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for STLN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
68236X100 (prev. 23343Q100 )
Market Cap
Small Cap
IPO
3/11/2020
Prospectus
IPO prospectus »
Previous Symbol
DFPH (changed 11/12/2021)
Previous Name
DFP Healthcare Acquisitions Corp.
Parent Company
DFP Healthcare Acquisitions Corp (TOI)
Business: Oncology Institute, Inc is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. The Company offers cutting-edge, evidence-based cancer care to a population of more than 1.5 million patients including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations.
Notes: AUTO-CRE

Company Contact

CEO
Steven Hochberg
CFO
Rob Carter
Headquarters
18000 Studebaker Rd., Cerritos, CA 90703
Phone
213-760-1328
Investor Relations
Maria Lycouris, Solebury Trout · mlycouris@soleburytrout.com
General Email
investors@theoncologyinstitute.com
SEC EDGAR Filings
View filings »